BeBetter Med
68875921.421.42% ( +0.30 )
BeBetter Med (688759)
BeBetter Med Inc., a biopharmaceutical company, engages in the research and development, and sale of drugs for oncology, metabolic diseases and central nervous...
- Open
- 21.58
- High
- 22.09
- Low
- 21.32
- Prev. Close
- 21.12
- Volume
- 66.00K
- Turnover
- 143.03M
- Avg Price
- 21.67
- Bid/Ask Ratio
- 2.94%
- Amplitude
- 3.65%
- 52wk High
- 57.47
- Volume Ratio
- 0.97
- Turnover Ratio
- 9.17%
News
- Wallstreetcn · Mar 16 at 09:28 PM
Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit
- Zhitong · Oct 27, 2025 at 08:40 PM
The Sci-Tech Innovation Board's Sci-Tech Growth Tier "welcomes" HeYuan Biotechnology, Xi'an YiCai, BeBetter, and others, all of which saw significant gains on their first day of listing
- Zhitong · Oct 27, 2025 at 08:30 PM
Four new stocks in the A-share market were listed for the first time, setting a new high for the number of listings in a single day this year
- Zhitong · Oct 26, 2025 at 03:09 AM
The first batch of 3 new stocks from the Sci-Tech Innovation Growth Sector will be listed on October 28
- Zhitong · Oct 22, 2025 at 06:17 PM
New regulations for institutions participating in IPOs of unprofitable companies take effect — "high" lock-up = "high" allocation
- Zhitong · Oct 22, 2025 at 06:06 AM
BeBetter: Initial public offering of 90 million shares and listing on the Sci-Tech Innovation Board
